Oprelvekin
Jump to navigation
Jump to search
| Oprelvekin | |
|---|---|
| Term | Oprelvekin |
| Short definition | OPPA scheme - An acronym for a combination of chemotherapy, often used with radiation therapy, to treat a certain type of childhood Hodgkin's lymphoma in women. It includes the drugs vincristine sulfate (Oncovin), prednisone, procarbazine hydrochloride, and doxorubicin hydrochloride (Adriamycin). |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
oprelvekin - (pronounced) (oh-PREL-veh-KIN) drug used to increase the number of blood cells, particularly platelets, in some cancer patients who are receiving chemotherapy. Oprelvekin is a laboratory-made form of interleukin-11 (a cytokine normally made by supporting cells in the bone marrow). It's a kind of biological response modifier. Also called Neumega, recombinant human interleukin-11 and rhIL-11
External links
- Medical encyclopedia article on Oprelvekin
- Wikipedia's article - Oprelvekin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski